SAMDaily.us | AWARD | A | Establishment of High Throughput SARS-CoV-2 Binding Antibody Immunoassay Capability and Testing of Human Serum Samples

SAMDAILY.US - ISSUE OF DECEMBER 25, 2020 SAM #6966
AWARD

A -- Establishment of High Throughput SARS-CoV-2 Binding Antibody Immunoassay Capability and Testing of Human Serum Samples

Notice Date: 12/23/2020 6:37:09 AM
Notice Type: Award Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
ZIP Code: 20515
Solicitation Number: 75A50121P00015
Archive Date: 12/23/2020
Award Number: 75A50121P00015
Award Date: 12/08/2020
Awardee: NEXELIS LABORATORIES CANADA INC Laval
Award Amount: 8023218.00
Description: The objectives of this contract are: (1) Contractor to establish a high throughput multiplex MSD-ECL immunoassay for COVID-19 for use in testing of serum samples from human subjects enrolled in clinical trials of COVID-19 vaccines in compliance with Good Clinical Laboratory Practice (GCLP); and (2) Contractor to provide the USG with serologic data to support establishment of a correlate of protection to help facilitate expanded use of approved COVID-19 vaccines and accelerated approvals of additional vaccines.
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/24fcc04b7d744d64a7de9a6e2a023e33/view)
Place of Performance: Address: Seattle, WA 98119, USA; Zip Code: 98119; Country: USA
Record: SN05880092-F 20201225/201223230108 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |